BERKLEY AND JENSEN LANSOPRAZOLE
NDC 68391-823, Lansoprazole, capsule, delayed release, from BJWC.
- Product NDC
- 68391-823
- Status
- Listed
- Labeler
- BJWC
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA202319
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68391-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LANSOPRAZOLE15 mg/1
Pharmacologic classes
Inhibition Gastric Acid Secretion [PE]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68391-823-03 | 68391082303 | 3 BOTTLE in 1 PACKAGE (68391-823-03) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE (68391-823-00) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 68391-823 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68391-823 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68391-823. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.